Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Repurposing Antipsychotic Agents Against Targets of Angiogenesis Pathways for Cancer Therapy: An in-silico Approach

2023Current Drug Discovery TechnologiesJournal

10.2174/1570163820666230606113158 Full text2 citations

Authors

9 authors across 3 institutions in 2 countries.

Rahmon Ilesanmi KanmodiFirst authorCorresponding
- Lagos State University (NG)
as printed: Rahmon Kanmodi
Habeeb. A. Bankole
- Lagos State University (NG)
as printed: Habeeb Bankole
Regina Oddiri
- Lagos State University (NG)
Michael Arowosegbe
Ridwan Alabi
- University of Lagos (NG)
Saheed Rahmon
- Lagos State University (NG)
Oladejo Ahmodu
- Lagos State University (NG)
Bilal AbdulRasheed
- Lagos State University (NG)
Rauf MuritalaSenior author
- Lagos State University (NG)

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Cancer, Stress, Anesthesia, and Immune Responselevel 3 · 0.36
Angiogenesis and VEGF in Cancerlevel 3 · 0.28
Phosphodiesterase function and regulationlevel 3 · 0.02

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2023 · Current Drug Discovery Technologies · 2 citations
https://openalex.org/W4379599164

Repurposing Antipsychotic Agents Against Targets of Angiogenesis Pathways for Cancer Therapy: An in-silico Approach · Sankore